Literature DB >> 17117045

Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case.

Yuichiro Sakamoto1, Kunihiro Mashiko, Hisashi Matsumoto, Yoshiaki Hara, Noriyosho Kutsukata, Kenkichi Takei, Yukihiro Ueno, Yoshiteru Tomita, Yasuhiro Yamamoto.   

Abstract

Because of the many difficult aspects in the treatment of septic shock and poor outcome of this condition, establishing the most appropriate therapeutic strategy is problematic. Recently, high mobility group box-1 (HMGB-1) has been shown to activate inflammatory responses and to be a late mediator in endotoxemia and sepsis. Therefore, we considered that it might be worthwhile to investigate the therapeutic potential of HMGB-1 blockade in cases of septic shock.Herein, we describe the case of a patient with septic shock with hepatic portal venous gas caused by intestinal obstruction. Hepatic portal venous gas is a rare condition associated with significant radiographic findings and a fatal outcome. Our patient, however, recovered from severe septic shock and was saved by the use of direct hemoperfusion with a polymyxin B immobilized fiber column (DHP-PMX). This treatment resulted in a decrease in the serum levels of endotoxin, interleukin-6 (IL-6), and HMGB-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117045     DOI: 10.1097/01.mat.0000248996.22865.ce

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  5 in total

1.  Moving from a cytotoxic to a cytokinic approach in the blood purification labyrinth: have we finally found Ariadne's thread?

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Willem Boer; Elisabeth De Waele; Viola Van Gorp; Jouke De Regt; Herbert D Spapen
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

2.  Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients.

Authors:  Yuichiro Sakamoto; Kunihiro Mashiko; Toru Obata; Hisashi Matsumoto; Yoshiaki Hara; Noriyoshi Kutsukata; Hiroyuki Yokota
Journal:  Indian J Crit Care Med       Date:  2010-01

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 4.  Nuclear antigens and auto/alloantibody responses: friend or foe in transplant immunology.

Authors:  Toshiaki Nakano; Chao-Long Chen; Shigeru Goto
Journal:  Clin Dev Immunol       Date:  2013-04-14

5.  Bench-to-bedside review: High-mobility group box 1 and critical illness.

Authors:  Mitchell P Fink
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.